Juha O Rinne Selected Research

Norepinephrine (Noradrenaline)

3/2015

Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juha O Rinne Research Topics

Disease

59	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 12/2002
26	Cognitive Dysfunction 11/2022 - 12/2008
25	Parkinson Disease (Parkinson's Disease) 01/2023 - 10/2002
22	Dementia (Dementias) 01/2022 - 11/2008
16	Neuroinflammatory Diseases 01/2023 - 02/2010
10	Inflammation (Inflammations) 01/2023 - 03/2010
8	Insulin Resistance 12/2023 - 11/2015
6	Atrophy 05/2024 - 11/2008
6	Amyloid Plaque 12/2023 - 02/2010
5	Normal Pressure Hydrocephalus 01/2019 - 12/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2010
3	Type 2 Diabetes Mellitus (MODY) 11/2022 - 01/2017
3	Amyloidosis 01/2018 - 12/2012
3	Disease Progression 01/2018 - 11/2008
2	Hypertension (High Blood Pressure) 11/2022 - 05/2017
2	Neurobehavioral Manifestations 01/2018 - 08/2011
2	Epilepsy (Aura) 11/2017 - 01/2017
2	Frontotemporal Dementia (Semantic Dementia) 01/2016 - 05/2015
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2016 - 05/2015
2	Gambling (Pathological Gambling) 05/2012 - 05/2012
2	Overweight 09/2008 - 09/2007
1	Dyskinesias (Dyskinesia) 01/2023
1	Hypercholesterolemia 11/2022
1	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2022
1	Synucleinopathies 01/2022
1	Weight Gain 10/2021
1	Nervous System Diseases (Neurological Disorders) 04/2021
1	Memory Disorders (Memory Loss) 04/2021
1	Obesity 04/2021
1	Brain Diseases (Brain Disorder) 12/2020
1	Tics (Tic) 12/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018
1	Lewy Body Disease (Lewy Body Dementia) 01/2018
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2017
1	Tremor (Tremors) 12/2017
1	Edema (Dropsy) 05/2016

Drug/Important Bio-Agent (IBA)

37	Amyloid (Amyloid Fibrils)IBA 05/2024 - 04/2008
20	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2012
19	Apolipoproteins E (ApoE)IBA 05/2024 - 05/2015
17	Amyloid beta-PeptidesIBA 12/2023 - 11/2008
16	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 01/2008
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
14	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2003
10	Dopamine (Intropin)FDA LinkGeneric 08/2014 - 11/2002
6	ApolipoproteinsIBA 12/2023 - 09/2004
6	flutemetamolIBA 01/2018 - 11/2012
6	Levodopa (L Dopa)FDA LinkGeneric 11/2012 - 10/2002
5	Insulin (Novolin)FDA Link 04/2021 - 03/2015
5	RacloprideIBA 05/2012 - 11/2003
4	C-Reactive ProteinIBA 01/2023 - 01/2017
4	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2022 - 05/2015
3	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2023 - 09/2013
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2021 - 08/2017
3	EnzymesIBA 01/2021 - 09/2004
3	Cholinergic Agents (Cholinergics)IBA 01/2018 - 12/2002
3	LigandsIBA 01/2017 - 03/2010
3	CarbonIBA 01/2017 - 04/2008
3	bapineuzumabIBA 05/2016 - 04/2010
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2015 - 11/2003
3	fluorodopa F 18IBA 05/2012 - 02/2001
3	AcetylcholinesteraseIBA 01/2012 - 12/2002
3	Deoxyglucose (2 Deoxy D glucose)IBA 12/2009 - 01/2003
2	Apolipoprotein E4IBA 02/2024 - 01/2023
2	Antisense OligonucleotidesIBA 10/2023 - 06/2023
2	KF18446IBA 01/2023 - 01/2021
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 01/2018
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 11/2002
2	ORM-12741IBA 12/2020 - 01/2017
2	Pemetrexed (MTA)FDA Link 01/2020 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2003
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2018 - 12/2002
2	Monoclonal AntibodiesIBA 08/2012 - 04/2010
1	Apolipoprotein E3IBA 02/2024
1	VaccinesIBA 12/2023
1	UmibecestatIBA 12/2023
1	CholesterolIBA 01/2023
1	Glial Fibrillary Acidic ProteinIBA 01/2023
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 11/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022
1	EndocannabinoidsIBA 01/2022
1	CannabinoidsIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	Hormones (Hormone)IBA 10/2021
1	FluorineIBA 04/2021
1	Cholinergic ReceptorsIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	C-PeptideIBA 01/2020
1	IronIBA 12/2017
1	LipidsIBA 05/2017
1	Cyclooxygenase InhibitorsIBA 01/2017
1	Lipoxygenase (Lipoxygenase-1)IBA 01/2017
1	ImmunosorbentsIBA 01/2016

Therapy/Procedure

3	Therapeutics 08/2017 - 02/2010
2	Immunotherapy 12/2023 - 08/2012
1	Drug Therapy (Chemotherapy) 01/2022